Angiomyolipoma is a type of noncancerous kidney tumor consisting of fat, muscle, and blood vessels. It can cause pain and other complications. In some cases, a doctor may remove it ...

An angiomyolipoma is a type of tumor that usually occurs in your kidneys. It is the most common benign (noncancerous) solid renal (kidney) tumor type. This tumor comprises thick-walled blood ...

For patients with tuberous sclerosis or sporadic lymphangioleiomyomatosis-associated angiomyolipomata, the angiomyolipoma response rate is significantly higher with everolimus than placebo, with ...

Little is known about the association of angiomyolipoma and adult renal-cell neoplasia. We studied the clinicopathologic features of 36 patients with concurrent angiomyolipoma and renal-cell ...

Did you know that certain medications can cause symptom of 'Angiomyolipoma'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.

Ham wrote that epithelioid angiomyolipoma is in the sarcoma family of cancers—a type that begin in the bones and connective tissue of the body. There are more than 70 types of sarcoma, and ...

The usual or classic renal angiomyolipoma (AML) is a benign mesenchymal tumor composed of a variable proportion of fat, spindle and epithelioid smooth muscle cells, and abnormal thick-walled ...

Hepatic angiomyolipoma is a rare benign mesenchymal neoplasm. Preoperative diagnosis is difficult because of its varied imaging features and non-specific clinical presentation. A research team led ...

Angiomyolipoma is the most common benign renal neoplasm1 and accounts for 0.3%–3% of all diagnoses of renal neoplasm.2 It is most often detected incidentally.1 However, when tumours reach 4 cm in ...

The time to angiomyolipoma progression was longer in patients on everolimus (hazard ratio [HR] 0.08, 95% CI 0.02-0.37; p<0.0001). Skin lesion response rate was higher in the everolimus arm.

January 10, 2008 — Year-long treatment with the immunosuppressive drug sirolimus led to shrinkage of angiomyolipoma tumors, with volume reduced by nearly 50%, along with improvement in lung ...

Late-stage trial showed 42% angiomyolipoma response rate. FDA granted accelerated approval to Novartis’ Afinitor® (everolimus) tablets for the treatment of adult patients with renal ...